Continuous Glucose Monitoring Systems Market Size is Likely to Grow US$ 9.56 Billion by 2027 At a CAGR 9.50%

March 22 02:06 2023
Continuous Glucose Monitoring Systems Market Size is Likely to Grow US$ 9.56 Billion by 2027 At a CAGR 9.50%
Continuous Glucose Monitoring Systems Market
The global continuous glucose monitoring systems market reached a value of US$ 5.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.56 Billion by 2027, exhibiting a growth rate (CAGR) of 9.50% during 2022-2027.

IMARC Group latest research study “Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, finds that the global continuous glucose monitoring systems market size reached a value of US$ 5.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.56 Billion by 2027, exhibiting a CAGR of 9.50% during 2022-2027.

Continuous glucose monitoring systems (CGMS) are advanced devices that use a sensor integrated with a transmitter to measure glucose concentration in interstitial fluid. They provide a comprehensive profile of diabetes, alert patients of high and low blood sugar levels, identify patterns, and provide insight into physical activity, medication choices, food portions, and stress.

Request a PDF Sample for more detailed market insights:

Continuous Glucose Monitoring Systems Market Trends and Drivers:

The growing geriatric population and the increasing prevalence of diabetes among people currently represent one of the key factors catalyzing demand for CGMS for measuring glucose and insulin. In addition, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels in patients is strengthening the market growth.

Moreover, key market players are introducing non-invasive CGMS devices as a convenient alternative that eliminates false readings, limits waste from disposable testing supplies, and helps avoid the pain of the needle. They are also focusing on the development of CGMS with enhanced accuracy, longer sensor life, and improved user experience, which is driving the market.

Furthermore, increasing investments in research and development (R&D) activities in the healthcare sector and the increasing demand for minimally invasive (MI) diagnostic tools are stimulating the growth of the market worldwide.

Continuous Glucose Monitoring Systems Market Report Scope

Report Coverage


Market size value in 2021

US$ 5.46 Billion

Market forecast in 2027

US$ 9.56 Billion

Growth Rate

CAGR of 9.50% from 2022 to 2027

Base year for estimation


Historical data


Forecast period


Global Continuous Glucose Monitoring Systems Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Continuous Glucose Monitoring Systems Companies:

A. Menarini Diagnostics S.r.l.

Abbott Laboratories (NYSE: ABT)

DexCom Inc. (NASDAQ: DXCM)

F. Hoffmann-La Roche AG

Glysens Incorporated

LifeScan Inc. (Johnson & Johnson) (NYSE: JNJ)

Medtronic PLC

Medtrum Technologies Inc.

Nemaura Medical Inc.

Novo Nordisk A/S

Senseonics Holdings Inc.

Waveform Technologies Inc.

The report has segmented the market on the basis of region, component, demographics and end user.

Breakup by Component:

  •  Sensors
  • Transmitters and Receivers 
  • Integrated Insulin Pumps

Breakup by Demographics:

  • Child Population (≤14 years)
  • Adult Population (>14 years) 

Breakup by End User:

  • Clinics and Diagnostics Centers
  • ICUs
  • Home Healthcare

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:134 N 4th St.
City: Brooklyn
State: NY
Country: United States